These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33856498)

  • 1. The Influence of Bosentan on MicroRNA-27a/PPARγ/ET-1 Signaling Pathway in Pulmonary Artery Hypertension.
    Zhao H; Guo A; Wang M; Cai Z; Liu X; Kong Q; Zhao C
    Pediatr Cardiol; 2021 Jun; 42(5):1141-1148. PubMed ID: 33856498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-27a/b mediates endothelin-1-induced PPARγ reduction and proliferation of pulmonary artery smooth muscle cells.
    Xie X; Li S; Zhu Y; Liu L; Pan Y; Wang J; Shi W; Song Y; Yang L; Gao L; Zang W; Li M
    Cell Tissue Res; 2017 Sep; 369(3):527-539. PubMed ID: 28484848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung.
    Kang BY; Park K; Kleinhenz JM; Murphy TC; Sutliff RL; Archer D; Hart CM
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):131-144. PubMed ID: 27612006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia mediates mutual repression between microRNA-27a and PPARγ in the pulmonary vasculature.
    Kang BY; Park KK; Green DE; Bijli KM; Searles CD; Sutliff RL; Hart CM
    PLoS One; 2013; 8(11):e79503. PubMed ID: 24244514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.
    Kang BY; Park KK; Kleinhenz JM; Murphy TC; Green DE; Bijli KM; Yeligar SM; Carthan KA; Searles CD; Sutliff RL; Hart CM
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):136-46. PubMed ID: 26098770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1 decreases endothelial PPARγ signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension.
    Wolf D; Tseng N; Seedorf G; Roe G; Abman SH; Gien J
    Am J Physiol Lung Cell Mol Physiol; 2014 Feb; 306(4):L361-71. PubMed ID: 24337925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation.
    Calvier L; Boucher P; Herz J; Hansmann G
    Circ Res; 2019 Jun; 124(12):1778-1785. PubMed ID: 31023188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostanoid EP
    Li HH; Hsu HH; Chang GJ; Chen IC; Ho WJ; Hsu PC; Chen WJ; Pang JS; Huang CC; Lai YJ
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L349-L359. PubMed ID: 29146573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin S promotes the development of pulmonary arterial hypertension.
    Chang CJ; Hsu HC; Ho WJ; Chang GJ; Pang JS; Chen WJ; Huang CC; Lai YJ
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L1-L13. PubMed ID: 31017016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-27b plays a role in pulmonary arterial hypertension by modulating peroxisome proliferator-activated receptor γ dependent Hsp90-eNOS signaling and nitric oxide production.
    Bi R; Bao C; Jiang L; Liu H; Yang Y; Mei J; Ding F
    Biochem Biophys Res Commun; 2015 May; 460(2):469-75. PubMed ID: 25795136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF21 attenuates pulmonary arterial hypertension via downregulation of miR-130, which targets PPARγ.
    Wang M; Su L; Sun J; Cai L; Li X; Zhu X; Song L; Li J; Tong S; He Q; Cai M; Yang L; Chen Y; Wang L; Huang X
    J Cell Mol Med; 2022 Feb; 26(4):1034-1049. PubMed ID: 34989130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor γ attenuates serotonin-induced pulmonary artery smooth muscle cell proliferation and apoptosis inhibition involving ERK1/2 pathway.
    Han X; Chen C; Cheng G; Liang L; Yao X; Yang G; You P; Shou X
    Microvasc Res; 2015 Jul; 100():17-24. PubMed ID: 25937083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling.
    Liu T; Zou XZ; Huang N; Ge XY; Yao MZ; Liu H; Zhang Z; Hu CP
    Life Sci; 2019 Jun; 227():64-73. PubMed ID: 31004656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the combination of endothelin receptor antagonists (ERA) and phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension (PAH) in pathologic human pulmonary arteries in an ex-vivo organ bath model.
    Englert L; Stadlbauer C; Spaeth M; Hofmann HS; Schneider C; Hatz RA; Preissler G; Michel S; Golovchenko S; Ried M; Hoenicka M
    Pulm Pharmacol Ther; 2021 Feb; 66():101985. PubMed ID: 33359621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.
    Zhou Z; Wan J; Hou X; Geng J; Li X; Bai X
    Cell Death Dis; 2017 Mar; 8(3):e2658. PubMed ID: 28277542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-27a Induces Mesangial Cell Injury by Targeting of PPARγ, and its In Vivo Knockdown Prevents Progression of Diabetic Nephropathy.
    Wu L; Wang Q; Guo F; Ma X; Ji H; Liu F; Zhao Y; Qin G
    Sci Rep; 2016 May; 6():26072. PubMed ID: 27184517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy.
    Hou X; Tian J; Geng J; Li X; Tang X; Zhang J; Bai X
    Oncotarget; 2016 Jul; 7(30):47760-47776. PubMed ID: 27351287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bosentan on plasma endothelin-1 concentration in patients with pulmonary arterial hypertension.
    Hiramoto Y; Shioyama W; Kuroda T; Masaki M; Sugiyama S; Okamoto K; Hirota H; Fujio Y; Hori M; Yamauchi-Takihara K
    Circ J; 2007 Mar; 71(3):367-9. PubMed ID: 17322637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Focus on Macitentan in the Treatment of Pulmonary Arterial Hypertension.
    Bedan M; Grimm D; Wehland M; Simonsen U; Infanger M; Krüger M
    Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):103-113. PubMed ID: 29719121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.